Stock 4768 OTSUKA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Otsuka Corporation

Equities

4768

JP3188200004

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-04 EDT 		5-day change 1st Jan Change
3,217 JPY +0.88% Intraday chart for Otsuka Corporation +3.37% +10.68%
06-25 Lundbeck and Otsuka Announce FDA Acceptance of sNDA Filing for Brexpiprazole in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder CI
06-13 Jefferies Adjusts Otsuka Corporation’s Price Target to 3,450 Yen From 3,925 Yen, Keeps at Buy MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lundbeck and Otsuka Announce FDA Acceptance of sNDA Filing for Brexpiprazole in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder
CI
Jefferies Adjusts Otsuka Corporation’s Price Target to 3,450 Yen From 3,925 Yen, Keeps at Buy
MT
Correction: Otsuka Pharmaceutical's PTSD Treatment Candidate Sees Statistically Significant Results in Two Out of Three Trials
MT
Japanese Shares Close Lower as JGB Yields Hit 12-Year High
MT
Otsuka Pharmaceutical's PTSD Treatment Candidate Fails to Meet Primary Endpoint in Phase 3 Trial
MT
Otsuka Holdings' Attributable Profit Soars 26% in Fiscal Q1
MT
Otsuka to stop development of Alzheimer's disease drug
RE
Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise
MT
Otsuka Holdings' Attributable Profit Jumps 26% in Q1
MT
Otsuka Holdings 2.32 Billion Yen Worth of Shares As Stock Compensation
MT
H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy
MT
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation
MT
Split: 2 of 1
FA
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia
MT
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical
MT
Jefferies Adjusts Otsuka Corporation’s Price Target to 7,850 Yen From 7,100 Yen, Keeps at Buy
MT
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka
DJ
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses
MT
Otsuka Holdings Lowers 2023 Profit Outlook
MT
Japan's Nikkei cruises to 34-year peak, briefly breaching 38,000 range
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4768 Stock
  4. News Otsuka Corporation